What is the interaction between Escitalopram (Cipralex) and Metoclopramide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Interaction between Escitalopram and Metoclopramide

There are no research papers to assist in answering this question regarding the specific interaction between Escitalopram (Cipralex) and Metoclopramide.

General Information about Escitalopram

  • Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of major depressive disorder (MDD) and anxiety disorder 1, 2, 3, 4.
  • It has a highly selective, potent, and dose-dependent inhibitory effect on the human serotonin transport 2, 3.
  • Escitalopram is effective and generally well tolerated in the treatment of moderate to severe generalised anxiety disorder (GAD) or social anxiety disorder (SAD), panic disorder (with or without agoraphobia) as well as obsessive-compulsive disorder (OCD) 4.
  • It has a low propensity for drug interactions, which is a potential benefit in the management of patients with comorbidities 1, 5, 3.

Pharmacokinetics of Escitalopram

  • Escitalopram is rapidly absorbed and reaches maximum plasma concentrations in approximately 3-4 hours after either single- or multiple-dose administration 5.
  • The elimination half-life of escitalopram is about 27-33 hours and is consistent with once-daily administration 5.
  • Escitalopram has low protein binding (56%) and is not likely to cause interactions with highly protein-bound drugs 5.
  • It is metabolised by the cytochrome P450 (CYP) isoenzymes CYP2C19, CYP2D6 and CYP3A4, but in vitro studies have shown that escitalopram has negligible inhibitory effects on CYP isoenzymes and P-glycoprotein, suggesting that escitalopram is unlikely to cause clinically significant drug-drug interactions 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.